|
Aug 8
|
Has Adaptive Biotechnologies (ADPT) Outpaced Other Medical Stocks This Year?
|
|
Aug 8
|
Adaptive Biotechnologies Corporation (NASDAQ:ADPT) Just Reported And Analysts Have Been Lifting Their Price Targets
|
|
Aug 7
|
Adaptive Biotechnologies Second Quarter 2025 Earnings: Beats Expectations
|
|
Aug 6
|
Why Adaptive Biotechnologies Stock Popped by Almost 6% on Wednesday
|
|
Aug 6
|
Adaptive Biotechnologies Corp (ADPT) Q2 2025 Earnings Call Highlights: Strong MRD Growth and ...
|
|
Aug 5
|
Here's What Key Metrics Tell Us About Adaptive Biotechnologies (ADPT) Q2 Earnings
|
|
Aug 5
|
Adaptive Biotechnologies (ADPT) Reports Q2 Loss, Beats Revenue Estimates
|
|
Aug 5
|
Adaptive Biotechnologies: Q2 Earnings Snapshot
|
|
Aug 5
|
Adaptive Biotechnologies Reports Second Quarter 2025 Financial Results
|
|
Jul 24
|
Adaptive Biotechnologies' (NASDAQ:ADPT) investors will be pleased with their strong 161% return over the last year
|
|
Jul 22
|
Adaptive Biotechnologies Corporation (ADPT) Rose on Solid Results
|
|
Jul 4
|
Are Medical Stocks Lagging Adaptive Biotechnologies (ADPT) This Year?
|
|
Jul 1
|
Adaptive Biotechnologies and Flatiron Health Announce Integration of clonoSEQ® MRD Testing into OncoEMR®
|
|
May 30
|
Adaptive Biotechnologies Highlights New Data at 2025 ASCO Annual Meeting and EHA 2025 Congress Demonstrating How clonoSEQ® MRD Assessment is Optimizing Patient Care and Drug Development in Lymphoid Cancers
|
|
May 29
|
SPRO Stock Soars 245% on GSK-Partnered UTI Drug Meeting Study Goal
|
|
May 29
|
U.S. Govt. Cancels $766M Funding Contract for Moderna's Bird Flu Shot
|
|
May 28
|
Adaptive Biotechnologies to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference
|
|
May 3
|
Adaptive Biotechnologies First Quarter 2025 Earnings: Beats Expectations
|
|
May 2
|
Sector Update: Health Care Stocks Higher Friday Afternoon
|
|
May 2
|
Adaptive Biotechnologies Shares Surge After Q1 Loss Narrows, Revenue Rises
|